| Serial Number | 79426083 |
| Word Mark | IPAX-BRIGHT |
| Filing Date | Tuesday, April 29, 2025 |
| Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
| Status Date | Thursday, January 29, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Scientific research in the nature of conducting clinical trials for others in the field of cancer; clinical research in the field of cancer; testing of pharmaceuticals; laboratory testing; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals |
| Pseudo Mark | IPAX BRIGHT |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 2, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Telix Pharmaceuticals Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Event Date | Event Description |
| Thursday, June 19, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, July 2, 2025 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, January 1, 2026 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, January 22, 2026 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, January 28, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 28, 2026 | APPLICATION FILING RECEIPT MAILED |
| Thursday, January 29, 2026 | ASSIGNED TO EXAMINER |
| Thursday, January 29, 2026 | NON-FINAL ACTION WRITTEN |
| Friday, January 30, 2026 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |